Cargando…

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth

BACKGROUND: Current administration of hydroxyprogesterone caproate (HPC) by intramuscular injection is associated with limitations, including the potential for human error and contamination, patient anxiety, and increased risk of needlestick injury. OBJECTIVE: To describe the design of an auto-injec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Travanty, Michael N, Calawa, Bryon, Shalaby, Waleed S, Jozwiakowski, Michael J, Haraldsen, Kyle B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064158/ https://www.ncbi.nlm.nih.gov/pubmed/30100767 http://dx.doi.org/10.2147/MDER.S157114

Ejemplares similares

Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
por: Chollet, John L., et al.
Publicado: (2012)

Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
por: Sibai, Baha, et al.
Publicado: (2020)

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
por: Vidaeff, Alex C, et al.
Publicado: (2013)

Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
por: Boggess, Kim A., et al.
Publicado: (2018)

Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
por: Garcia, Stephanie M., et al.
Publicado: (2021)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth
por: Rouholamin, Safoura, et al.
Publicado: (2015)

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
por: Cohen, Gal, et al.
Publicado: (2022)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth – A Systematic Review and Meta-analysis Taking into Account the PROLONG Trial
por: Kuon, Ruben-J., et al.
Publicado: (2021)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial
por: Combs, C Andrew, et al.
Publicado: (2011)

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
por: Price, Joan T., et al.
Publicado: (2019)

Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
por: Egerman, Robert, et al.
Publicado: (2014)

17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB Activation
por: Hu, Tao, et al.
Publicado: (2022)

Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
por: Price, Joan T, et al.
Publicado: (2021)

In Utero Exposure to 17α-Hydroxyprogesterone Caproate May Contribute to Increasing Incidence Rates of Early-Onset Cancer
por: Murphy, Caitlin C, et al.
Publicado: (2021)

SUN-255 The Synthetic Progestin, 17-alpha-hydroxyprogesterone Caproate, Used in Human Pregnancy Alters Prefrontal Cortical Development in Rats
por: Lolier, Melanie L, et al.
Publicado: (2020)

17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant rats
por: Amaral, Lorena M., et al.
Publicado: (2020)

17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials
por: Baradwan, Saeed, et al.
Publicado: (2021)

Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery
por: Edwards, Evan T., et al.
Publicado: (2015)

Improving Uptake and Adherence to 17-Hydroxyprogesterone Caproate in Non-Hispanic Black Women: A Mixed Methods Study of Potential Interventions from the Patient Perspective
por: Wheeler, Sarahn M., et al.
Publicado: (2019)

Prescribing of adrenaline auto-injectors
por: Kahlon, Gurnaaz Kaur
Publicado: (2015)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

Subcutaneous Injection Performance in Yucatan Miniature Pigs with and without Human Hyaluronidase and Auto-injector Tolerability in Humans
por: Shi, Galen H., et al.
Publicado: (2021)

Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone
por: Kim, Laura, et al.
Publicado: (2014)

Global disparities in availability of epinephrine auto-injectors
por: Tanno, Luciana Kase, et al.
Publicado: (2023)

Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept
por: Dehoratius, Raphael J., et al.
Publicado: (2018)

Prescribing adrenaline auto-injectors in Slovenian children
por: Vesel, Tina, et al.
Publicado: (2015)

Mistaking an Auto-injector for a Ballpoint Pen
por: Maeda, Atsuo, et al.
Publicado: (2020)

Design Development of the SMARTCLIC(®)/CLICWISE(®) Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies
por: Berman, Kyle, et al.
Publicado: (2023)

Formative Study on the Wearability and Usability of a Large-Volume Patch Injector
por: Lange, Jakob, et al.
Publicado: (2021)

Comparison of the robustness and functionality of three adrenaline auto-injectors
por: Schwirtz, Andreas, et al.
Publicado: (2012)

An open-label trial of alsuma auto-injector for migraine
por: Ramos, E, et al.
Publicado: (2013)

Adrenaline auto-injector prescription and patients’ administration proficiency
por: Amaral, Luis, et al.
Publicado: (2015)

Update on the usage and safety of epinephrine auto-injectors, 2017
por: Posner, Larry S, et al.
Publicado: (2017)

What factors affect the carriage of epinephrine auto-injectors by teenagers?
por: Macadam, Clare, et al.
Publicado: (2012)

Unintentional injection to the bone with a pediatric epinephrine auto-injector
por: Ibrahim, Mariam, et al.
Publicado: (2018)

Epinephrine auto-injector needle length: The impact of winter clothing
por: Dreborg, Sten, et al.
Publicado: (2020)

Pediatric Epinephrine Auto-injector Accident Without Digital Ischemia
por: Shapiro, Alex L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3sishg2lrq7rpio4vc1vjjk3qb